SEC Form 4/A · accession 0001209191-18-038886
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert Berman
Officer — Chief Medical Officer
Period of report
Jun 8, 2018
Accepted (ET)
Jun 20, 2018 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Jun 11, 2018 | S | 4,409 | $35.25 | D | 316,283 | I | By Berman Marital Trust 2013 |
| Common SharesF3 | Jun 11, 2018 | S | 55,907 | $36.15 | D | 260,376 | I | By Berman Marital Trust 2013 |
| Common Shares | Jun 11, 2018 | S | 100 | $36.65 | D | 260,276 | I | By Berman Marital Trust 2013 |
| Common SharesF4 | Jun 12, 2018 | S | 10,647 | $37.07 | D | 249,629 | I | By Berman Marital Trust 2013 |
| Common SharesF5 | Jun 12, 2018 | S | 5,629 | $38.00 | D | 244,000 | I | By Berman Marital Trust 2013 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.63 - $35.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.63 - $36.61, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.73 - $37.72, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.74 - $38.28, inclusive.
Remarks
This amended report is being filed to correct the number of shares beneficially owned by the Reporting Person after each reported transaction to correct a mathematical error in the original filing.